DK1330262T3 - Anvendelse af enzymer udvundet fra ciliater som lægemidler til fremme af fordöjelsen - Google Patents

Anvendelse af enzymer udvundet fra ciliater som lægemidler til fremme af fordöjelsen

Info

Publication number
DK1330262T3
DK1330262T3 DK01992585T DK01992585T DK1330262T3 DK 1330262 T3 DK1330262 T3 DK 1330262T3 DK 01992585 T DK01992585 T DK 01992585T DK 01992585 T DK01992585 T DK 01992585T DK 1330262 T3 DK1330262 T3 DK 1330262T3
Authority
DK
Denmark
Prior art keywords
ciliates
drugs
promote digestion
enzymes derived
enzymes
Prior art date
Application number
DK01992585T
Other languages
English (en)
Inventor
Marcus Hartmann
Original Assignee
Cilian Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cilian Ag filed Critical Cilian Ag
Application granted granted Critical
Publication of DK1330262T3 publication Critical patent/DK1330262T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nutrition Science (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
DK01992585T 2000-11-02 2001-11-02 Anvendelse af enzymer udvundet fra ciliater som lægemidler til fremme af fordöjelsen DK1330262T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10054239 2000-11-02
PCT/EP2001/012740 WO2002036156A1 (de) 2000-11-02 2001-11-02 Verwendung von aus ciliaten gewonnenen enzymen als verdauungsfördernde arzneimittel

Publications (1)

Publication Number Publication Date
DK1330262T3 true DK1330262T3 (da) 2005-09-19

Family

ID=7661849

Family Applications (1)

Application Number Title Priority Date Filing Date
DK01992585T DK1330262T3 (da) 2000-11-02 2001-11-02 Anvendelse af enzymer udvundet fra ciliater som lægemidler til fremme af fordöjelsen

Country Status (16)

Country Link
US (2) US20040033220A1 (da)
EP (1) EP1330262B1 (da)
JP (1) JP4139215B2 (da)
CN (1) CN1262308C (da)
AT (1) ATE295737T1 (da)
AU (2) AU2002223666B2 (da)
CA (1) CA2427537A1 (da)
DE (1) DE50106273D1 (da)
DK (1) DK1330262T3 (da)
ES (1) ES2239686T3 (da)
IL (2) IL155515A0 (da)
NO (1) NO20031979L (da)
PL (1) PL204599B1 (da)
PT (1) PT1330262E (da)
RU (1) RU2299074C2 (da)
WO (1) WO2002036156A1 (da)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2544156C (en) * 2003-10-29 2012-07-10 Altus Pharmaceuticals Inc. Non-pancreatic proteases for controlling plasma cholecystokinin (cck) concentration and for treating pain
ES2314646T3 (es) * 2004-03-22 2009-03-16 Solvay Pharmaceuticals Gmbh Composiciones farmaceuticas por via de productos que contienen lipasa , en particular de pancreatina, que contienen tensioactivos.
WO2005098427A2 (en) * 2004-04-05 2005-10-20 Arbab Saccharides Science & Technology Co. Ltd Method, composition and device for treating starch related diseases
WO2005099748A1 (de) * 2004-04-13 2005-10-27 Cilian Ag Rekombinante lysosomale enzyme mit ciliaten-typischem glykosylierungsmuster für die therapie
HUE031042T2 (en) 2005-07-29 2017-06-28 Abbott Laboratories Gmbh Methods for producing pancreatin powder with low viral content
US9198871B2 (en) 2005-08-15 2015-12-01 Abbott Products Gmbh Delayed release pancreatin compositions
US11266607B2 (en) * 2005-08-15 2022-03-08 AbbVie Pharmaceuticals GmbH Process for the manufacture and use of pancreatin micropellet cores
WO2007053619A2 (en) * 2005-11-01 2007-05-10 Bio-Cat, Inc. A composition with a fungal (yeast) lipase and method for treating lipid malabsorption in cystic fibrous as well as people suffering from pancreatic lipase insufficiency
US10072256B2 (en) * 2006-05-22 2018-09-11 Abbott Products Gmbh Process for separating and determining the viral load in a pancreatin sample
RU2385158C2 (ru) * 2007-07-03 2010-03-27 Государственное научное учреждение Всероссийский научно-исследовательский институт мясной промышленности им. В.М. Горбатова Российской академии сельскохозяйственных наук Средство для лечения диареи у поросят "колимак", способ его получения и способ лечения диареи у поросят
US20090130063A1 (en) * 2007-11-15 2009-05-21 Solvay Pharmaceuticals Gmbh Process for separating and determining the viral load in a pancreatin sample
WO2010037695A1 (en) * 2008-09-30 2010-04-08 Dsm Ip Assets B.V. Enzyme composition and application thereof in the treatment of pancreatic insufficiency
GB201501081D0 (en) * 2015-01-22 2015-03-11 Cilian Ag Use of enzymes with a wide pH activity range as medicaments for promoting digestion
EP4172325A1 (en) * 2020-06-24 2023-05-03 Cilian AG New lipase enzyme
JP2024513114A (ja) * 2021-04-09 2024-03-21 シリアン アクチェンゲゼルシャフト タンパク質の精製

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE454566B (sv) * 1984-04-24 1988-05-16 Lars G I Hellgren Farmaceutisk komposition innehallande en verksam mengd av vattenlosliga proteinaser som extraherats fran ett vattenlevande djur valt av ordningen euphausiaceae eller slektet mallotus
WO1993000924A1 (de) * 1991-07-01 1993-01-21 Basf Aktiengesellschaft Verwendung von lipasen zur herstellung von arzneimitteln
DE4238842A1 (de) * 1992-11-17 1994-05-19 Arno Prof Dr Tiedtke Hochzelldichte Fermentation von Ciliaten zur Gewinnung von Naturstoffen
DE19524307A1 (de) * 1995-07-07 1997-01-09 Hoechst Ag Verfahren zur Massenkultivierung von Ciliaten
DE19724845A1 (de) * 1996-08-28 1998-03-05 Solvay Pharm Gmbh Verwendung von komplexen Lipiden als stabilisierende Zusätze zu pharmazeutischen Zubereitungen von Verdauungsenzymgemischen
US6846481B1 (en) * 1999-02-04 2005-01-25 University Of Georgia Research Foundation, Inc. Recombinant expression of heterologous nucleic acids in protozoa
US6539128B1 (en) * 1999-04-16 2003-03-25 Macronix International Co., Ltd. Method and apparatus for interpolation
US6543100B1 (en) * 2001-09-24 2003-04-08 Christopher J. Finley Test tube retention system

Also Published As

Publication number Publication date
IL155515A0 (en) 2003-11-23
CN1262308C (zh) 2006-07-05
NO20031979L (no) 2003-06-30
PL204599B1 (pl) 2010-01-29
DE50106273D1 (de) 2005-06-23
WO2002036156A1 (de) 2002-05-10
AU2002223666B2 (en) 2006-08-24
EP1330262B1 (de) 2005-05-18
HK1057861A1 (en) 2004-04-23
JP2004512375A (ja) 2004-04-22
PL361630A1 (en) 2004-10-04
EP1330262A1 (de) 2003-07-30
JP4139215B2 (ja) 2008-08-27
RU2299074C2 (ru) 2007-05-20
IL155515A (en) 2009-02-11
AU2366602A (en) 2002-05-15
CN1484530A (zh) 2004-03-24
ATE295737T1 (de) 2005-06-15
CA2427537A1 (en) 2002-05-10
ES2239686T3 (es) 2005-10-01
PT1330262E (pt) 2005-07-29
US20040033220A1 (en) 2004-02-19
NO20031979D0 (no) 2003-04-30
US20080292610A1 (en) 2008-11-27

Similar Documents

Publication Publication Date Title
NO20031979L (no) Anvendelse av enzymer oppnådd fra ciliater som medikamenter for å fremme fordöyelse
MXPA03007527A (es) Enzimas que tienen actividad de alfa amilasa y metodos de uso de las mismas.
DK1268847T3 (da) Ubiquitin-ligaseassay
ATE373086T1 (de) Enzyme des auf die lysosomen gerichteten weges
DK1755656T3 (da) Enzymer til farmaceutisk anvendelse
EA201171291A1 (ru) Кормовая добавка
WO2008021987A3 (en) Proteolytic enzyme formulations
JP2008521906A5 (da)
ATE424894T1 (de) Zusammensetzung zur förderung des haarwachstums
DE60042209D1 (de) Enzymatische synthese von deoxyribonucleotiden
NO20042601L (no) Ny peptid med angiotensinkonvertasehemmende effekt
WO2008019069A3 (en) Enzymatic aqueous acylation
DK1001761T3 (da) Anvendelse af cholinesteraseinhibitorer til behandling af opmærksomhedsunderskudslidelser
AU2002223666A1 (en) Use of enzymes obtained from ciliates as medicaments for promoting digestion
ATE267863T1 (de) Flüssige entkalkungs-zusammensetzung
AR030593A1 (es) Sistema tensioactivo
WO2007085428A3 (de) Mund-und zahnpflege und-remigungsmittel mit enzymen'
DE60029624D1 (de) Homologe enzyme der humanen heparanase sowie alternative spleissformen davon
DE60326048D1 (de) Kristallstruktur des angiotensin-konvertierenden enzyms (ace) und ihre verwendung
PT1244614E (pt) Inibidores de triptase
MX2009004611A (es) Formulaciones de inhibidores de enzimas de fosfolipasa.
ATE273394T1 (de) Wirts-vektor-systeme zur phosphatregulierten überproduktion von polypeptiden in bacillus
PL359727A1 (en) Crystalline pharmaceutical
ATE282702T1 (de) Lytisches enzym
EP1315794A4 (en) Genetic demonstration of requirement for nkx6.1, nkx2.2 and nkx6.2 in ventral neuron generation